Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
Annals of Translational Medicine|August 5, 2021
Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative reviewYiyi Cai, Boyuan Wang, Bingying Li, et al.Clinical Lung Cancer|April 4, 2018
Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous CarcinomaYiwei Liu, Zhengwei Dong, Tao Jiang, et al.Theranostics|June 7, 2021
Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLCYayi He, Linsong Chen, Lishu Zhao, et al.Lung Cancer (Amsterdam, Netherlands)|December 2, 2019
Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLCShuo Yang, Shiqi Mao, Xuefei Li, et al.Translational Lung Cancer Research|March 15, 2021
Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutationsShuo Yang, Yan Wang, Chao Zhao, et al.Nature Cancer|April 22, 2022
Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancerChenchen Guo, Ruijie Wan, Yayi He, et al.National Science Review|December 17, 2024
Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic targetHua Wang, Shijie Tang, Qibiao Wu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2021
Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung CancerYayi He, Lele Song, Hao Wang, et al.Nature Communications|May 6, 2021
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancerFengying Wu, Jue Fan, Yayi He, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 25, 2021
[Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2020 Version)]Caicun Zhou, Jie Wang, Baocheng Wang, et al.Pageof 16